AI summary is being generated. Check back soon for a plain-language breakdown of this bill.
Positive media analysis is being generated.
Critical media analysis is being generated.
Senator Todd Gardenhire sponsors SB0215, which establishes penalties for selling or distributing hemp-derived cannabinoids to individuals under 21. His personal financial interests include significant investments in pharmaceutical companies such as Pfizer and Eli Lilly & Co., which are directly related to the health products industry. Given that the bill addresses the regulation of products containing cannabinoids, there is a potential conflict as the bill could influence the market dynamics of health-related products, including those produced by these pharmaceutical companies.
The alignment of Senator Gardenhire's financial interests with the pharmaceutical sector raises concerns about whether his legislative actions could be influenced by personal financial gain. If the bill results in increased regulation or penalties that affect the sale of hemp-derived products, it could inadvertently benefit the pharmaceutical companies in which he has invested, particularly if they offer alternative health products. This direct financial connection warrants a high-risk assessment regarding potential conflicts of interest.
Unlike federal analysis based on campaign donations, state analysis examines legislators' personal financial interests — their jobs, businesses, and investments.
| Type | Description | Industry | Source |
|---|---|---|---|
| Occupation | Financial Advisor | — | AI-researched |
| Employer | Retired from Morgan Stanley | Securities & Investment | TN Legislature bio |
| Board Member | Board member of the Tennessee Student Assistance Corporation | — | TN Legislature bio |
| Spouse Employer | INTERNATIONAL BUSINESS MACHINE PENSION ANNUITY | — | TN Ethics Commission |
| Employer | METLIFE PENSION ANNUITY | — | TN Ethics Commission |
| Employer | SOCIAL SECURITY | — | TN Ethics Commission |
| Employer | SEP IRA RMD | — | TN Ethics Commission |
| Employer | MORGAN STANLEY COMMON STOCK | Securities & Investment | TN Ethics Commission |
| Asset | MORGAN STANLEY COMMON | Securities & Investment | TN Ethics Commission |
| Asset | BROWN CAPITAL SMALL CAP | — | TN Ethics Commission |
| Asset | JANUS HENDERSON ENTERPRISE N | — | TN Ethics Commission |
| Asset | ALLIANZ NFJ LARGE CAP VALUE | — | TN Ethics Commission |
| Asset | NATIONAL HEALTHCARE CORP | — | TN Ethics Commission |
| Asset | SPROTT PHYSICAL GOLD TRUST | — | TN Ethics Commission |
| Asset | CUSIP 9128285T3 | — | TN Ethics Commission |
| Asset | CUSIP 912828XZ8 | — | TN Ethics Commission |
| Asset | CUSIP 91282CEU1 | — | TN Ethics Commission |
| Asset | CUSIP 91282CFP1 | — | TN Ethics Commission |
| Asset | FIFTH 3D BANCORP | — | TN Ethics Commission |
| Asset | FIRST HORIZON CORP | — | TN Ethics Commission |
| Asset | REGIONS FINANCIAL | — | TN Ethics Commission |
| Asset | ASTEC INC. | — | TN Ethics Commission |
| Asset | SANOFI | — | TN Ethics Commission |
| Asset | PFIZER | Pharmaceuticals/Health Products | TN Ethics Commission |
| Asset | ELI LILLY & CO | Pharmaceuticals/Health Products | TN Ethics Commission |
| Asset | BRISTOL MYERS SQUIBB & CO | — | TN Ethics Commission |
| Asset | ASTRAZENECA PLC ADR | — | TN Ethics Commission |
| Asset | EXXON MOBIL | Oil & Gas | TN Ethics Commission |
Items marked "AI-researched" are generated from public sources but have not been independently verified. Verified data is sourced from official legislature websites and disclosure filings.
About This Analysis
This summary was generated using AI from the bill's official text and metadata. Data sourced from LegiScan and the Tennessee General Assembly. Conflict analysis examines the sponsor's personal financial interests for potential overlaps with the bill's subject matter.
TN SB0215